(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...
A New York exhibition pays homage to a Black woman who passed as white and assembled the financier’s private collection ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback